IOFLUPANE I-123

IOFLUPANE I-123 was reported 545 times

IOFLUPANE I-123 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FALSE POSITIVE RADIOISOTOPE INVESTIGATION RESULT 16 0.7273
1 DOPAMINE TRANSPORTER SCINTIGRAPHY ABNORMAL 13 0.3939
2 RADIOISOTOPE SCAN ABNORMAL 149 0.2107
3 RADIOISOTOPE UPTAKE INCREASED 2 0.0455
4 IODINE UPTAKE INCREASED 1 0.0400
5 OCCUPATIONAL EXPOSURE TO RADIATION 1 0.0286
6 THERAPEUTIC AGENT-DIAGNOSTIC TEST INTERACTION 1 0.0217
7 RADIATION OVERDOSE 1 0.0185
8 MYOCARDIAL STUNNING 1 0.0075
9 BRAIN SCAN ABNORMAL 4 0.0072
10 FALSE NEGATIVE INVESTIGATION RESULT 5 0.0071
11 FALSE POSITIVE INVESTIGATION RESULT 7 0.0069
12 THYROID PAIN 1 0.0056
13 LABELLED DRUG-DRUG INTERACTION ISSUE 4 0.0028
14 SCAN ABNORMAL 1 0.0027
15 PARKINSONISM 26 0.0027
16 NO ADVERSE EVENT 263 0.0015
17 CONTRAST MEDIA ALLERGY 2 0.0011
18 INTRACRANIAL MASS 1 0.0011
19 ADMINISTRATION SITE PAIN 1 0.0009
20 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
21 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
22 INJECTION SITE PARAESTHESIA 1 0.0007
23 INHIBITORY DRUG INTERACTION 1 0.0006
24 GLIOBLASTOMA 1 0.0006
25 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
26 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
27 AURA 1 0.0005
28 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
29 SKIN HYPERTROPHY 1 0.0004
30 BURNING SENSATION 24 0.0003
31 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
32 DRUG INTERACTION 49 0.0003
33 FREEZING PHENOMENON 1 0.0003
34 HAEMORRHAGIC STROKE 2 0.0003
35 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
36 ANAPHYLACTOID REACTION 1 0.0002
37 TENSION HEADACHE 1 0.0002
38 PULSE ABSENT 1 0.0002
39 INJECTION SITE PAIN 59 0.0002
40 FEELING COLD 5 0.0002
41 ACUTE PULMONARY OEDEMA 1 0.0002
42 ENCEPHALITIS 1 0.0001
43 FORMICATION 1 0.0001
44 APNOEA 1 0.0001
45 FACIAL PARALYSIS 1 0.0001
46 FLANK PAIN 1 0.0001
47 DRUG INEFFECTIVE 130 0.0001
48 MOTOR DYSFUNCTION 1 0.0001
49 INCONTINENCE 1 0.0001
50 HYPERTENSIVE CRISIS 1 0.0001
51 OCULAR DISCOMFORT 1 0.0001
52 THYROID CANCER 1 0.0001
53 PRESYNCOPE 2 0.0001
54 PRODUCT QUALITY ISSUE 11 0.0001
55 PNEUMONIA ASPIRATION 2 0.0001
56 UNRESPONSIVE TO STIMULI 2 0.0001
57 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
58 SENSORY DISTURBANCE 1 0.0001
59 HYPERKALAEMIA 2 0.0001
60 PANIC ATTACK 2 0.0001
61 DYSGEUSIA 4 0.0001
62 EYE SWELLING 2 0.0001
63 BLOOD SODIUM DECREASED 1 0.0001
64 CHOKING 1 0.0001
65 SINUS DISORDER 1 0.0001
66 PRODUCT ADMINISTRATION ERROR 1 0.0000
67 DYSKINESIA 2 0.0000
68 RETCHING 1 0.0000
69 PRURITUS GENERALISED 1 0.0000
70 INFUSION RELATED REACTION 3 0.0000
71 SNEEZING 1 0.0000
72 SEIZURE 5 0.0000
73 OROPHARYNGEAL PAIN 4 0.0000
74 CEREBRAL INFARCTION 1 0.0000
75 HAEMATEMESIS 1 0.0000
76 ANAPHYLACTIC SHOCK 1 0.0000
77 THROAT TIGHTNESS 1 0.0000
78 SKIN LESION 1 0.0000
79 RESPIRATORY ARREST 1 0.0000
80 DEMENTIA 1 0.0000
81 VERTIGO 2 0.0000
82 FEELING HOT 2 0.0000
83 DRUG ADMINISTRATION ERROR 1 0.0000
84 SWELLING 3 0.0000
85 LOSS OF CONSCIOUSNESS 4 0.0000
86 HYPERHIDROSIS 4 0.0000
87 ABDOMINAL DISCOMFORT 5 0.0000
88 CHEST DISCOMFORT 3 0.0000
89 HEART RATE DECREASED 1 0.0000
90 LYMPHADENOPATHY 1 0.0000
91 DYSARTHRIA 1 0.0000
92 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
93 DISORIENTATION 1 0.0000
94 EXTRA DOSE ADMINISTERED 1 0.0000
95 DRY MOUTH 2 0.0000
96 ERYTHEMA 5 0.0000
97 CARDIO-RESPIRATORY ARREST 1 0.0000
98 BALANCE DISORDER 2 0.0000
99 MALAISE 10 0.0000
100 ANGIOEDEMA 1 0.0000
101 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
102 VISION BLURRED 3 0.0000
103 SKIN DISCOLOURATION 1 0.0000
104 RASH ERYTHEMATOUS 1 0.0000
105 DIZZINESS 10 0.0000
106 SYNCOPE 2 0.0000
107 NERVOUSNESS 1 0.0000
108 OEDEMA 1 0.0000
109 NECK PAIN 1 0.0000
110 BLISTER 1 0.0000
111 HYPONATRAEMIA 1 0.0000
112 HEADACHE 11 0.0000
113 PRODUCT SUBSTITUTION ISSUE 1 0.0000
114 ILL-DEFINED DISORDER 1 0.0000
115 NAUSEA 13 0.0000
116 SWELLING FACE 1 0.0000
117 BLOOD PRESSURE DECREASED 1 0.0000
118 INJECTION SITE PRURITUS 1 0.0000
119 VOMITING 7 0.0000
120 PAIN 9 0.0000
121 INJECTION SITE REACTION 1 0.0000
122 UNDERDOSE 1 0.0000
123 HYPOAESTHESIA 2 0.0000
124 HOT FLUSH 1 0.0000
125 ARTHRITIS 1 0.0000
126 INFLUENZA LIKE ILLNESS 1 0.0000
127 TREMOR 2 0.0000
128 MUSCULOSKELETAL STIFFNESS 1 0.0000
129 DYSPHAGIA 1 0.0000
130 MIGRAINE 1 0.0000
131 SOMNOLENCE 2 0.0000
132 FLUSHING 1 0.0000
133 ILLNESS 1 0.0000
134 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
135 ABDOMINAL DISTENSION 1 0.0000
136 HAEMORRHAGE 1 0.0000
137 MUSCULAR WEAKNESS 1 0.0000
138 INCORRECT DOSE ADMINISTERED 2 0.0000
139 ABDOMINAL PAIN 2 0.0000
140 CHILLS 1 0.0000
141 FEELING ABNORMAL 2 0.0000
142 INJECTION SITE ERYTHEMA 1 0.0000
143 PRURITUS 3 0.0000
144 FATIGUE 6 0.0000
145 DYSPNOEA 4 0.0000
146 ANXIETY 2 0.0000
147 RASH 3 0.0000
148 ACUTE KIDNEY INJURY 1 0.0000
149 PARAESTHESIA 1 0.0000
150 MUSCLE SPASMS 1 0.0000
151 HYPERSENSITIVITY 1 0.0000
152 ASTHENIA 2 0.0000
153 BLOOD GLUCOSE INCREASED 1 0.0000
154 GAIT DISTURBANCE 1 0.0000
155 HYPOTENSION 1 0.0000
156 ABDOMINAL PAIN UPPER 1 0.0000
157 HYPERTENSION 1 0.0000
158 DIARRHOEA 3 0.0000
159 DEPRESSION 1 0.0000
160 OFF LABEL USE 3 0.0000
161 FALL 1 0.0000
162 PYREXIA 1 0.0000
163 ARTHRALGIA 1 0.0000